| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Azides | 8 | 2018 | 116 | 1.040 |
Why?
|
| Positron-Emission Tomography | 25 | 2018 | 6234 | 0.960 |
Why?
|
| Caspase 3 | 8 | 2016 | 758 | 0.950 |
Why?
|
| Fluorine Radioisotopes | 9 | 2014 | 442 | 0.890 |
Why?
|
| Apoptosis | 15 | 2018 | 9727 | 0.740 |
Why?
|
| Radiopharmaceuticals | 15 | 2015 | 2645 | 0.690 |
Why?
|
| Caspase 7 | 3 | 2015 | 56 | 0.590 |
Why?
|
| rho GTP-Binding Proteins | 3 | 2005 | 293 | 0.470 |
Why?
|
| Indoles | 5 | 2018 | 1839 | 0.460 |
Why?
|
| Choline | 5 | 2016 | 493 | 0.460 |
Why?
|
| Colonic Neoplasms | 7 | 2014 | 2541 | 0.400 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 5 | 2006 | 93 | 0.390 |
Why?
|
| Fluorodeoxyglucose F18 | 7 | 2016 | 2016 | 0.370 |
Why?
|
| Choline Kinase | 2 | 2016 | 5 | 0.350 |
Why?
|
| Cyclophosphamide | 2 | 2013 | 2242 | 0.350 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2013 | 627 | 0.340 |
Why?
|
| Receptors, CXCR4 | 4 | 2014 | 726 | 0.330 |
Why?
|
| rhoA GTP-Binding Protein | 4 | 2005 | 241 | 0.320 |
Why?
|
| HCT116 Cells | 8 | 2018 | 408 | 0.310 |
Why?
|
| Neoplasm Invasiveness | 10 | 2014 | 3616 | 0.310 |
Why?
|
| Receptor, PAR-1 | 2 | 2005 | 113 | 0.300 |
Why?
|
| Cell Proliferation | 10 | 2018 | 10481 | 0.290 |
Why?
|
| Dideoxynucleosides | 3 | 2018 | 122 | 0.290 |
Why?
|
| Semaphorin-3A | 1 | 2006 | 39 | 0.290 |
Why?
|
| Isatin | 3 | 2012 | 5 | 0.280 |
Why?
|
| Quinazolines | 4 | 2016 | 1356 | 0.280 |
Why?
|
| Neoplasms | 13 | 2016 | 21683 | 0.280 |
Why?
|
| Mice, Nude | 13 | 2018 | 3689 | 0.250 |
Why?
|
| Triazoles | 2 | 2010 | 911 | 0.250 |
Why?
|
| Ki-67 Antigen | 4 | 2016 | 644 | 0.240 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 1177 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2018 | 3557 | 0.220 |
Why?
|
| Deuterium | 3 | 2012 | 101 | 0.220 |
Why?
|
| Aminopyridines | 2 | 2016 | 542 | 0.210 |
Why?
|
| Receptors, Thrombin | 1 | 2002 | 131 | 0.200 |
Why?
|
| Gene Silencing | 2 | 2018 | 1538 | 0.190 |
Why?
|
| Peptides, Cyclic | 2 | 2013 | 400 | 0.190 |
Why?
|
| Cell Line, Tumor | 19 | 2018 | 16689 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 13 | 2016 | 6386 | 0.190 |
Why?
|
| Botulinum Toxins | 1 | 2002 | 191 | 0.180 |
Why?
|
| Mice, Inbred C3H | 2 | 2013 | 964 | 0.180 |
Why?
|
| Radioactive Tracers | 4 | 2013 | 72 | 0.180 |
Why?
|
| Peer Review, Health Care | 1 | 2019 | 75 | 0.160 |
Why?
|
| Neoplasms, Experimental | 3 | 2014 | 1276 | 0.160 |
Why?
|
| Thymidine Kinase | 3 | 2014 | 290 | 0.160 |
Why?
|
| Diagnostic Imaging | 2 | 2016 | 3507 | 0.160 |
Why?
|
| Ubiquitin C | 1 | 2017 | 2 | 0.160 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2018 | 97 | 0.160 |
Why?
|
| Mice | 30 | 2018 | 81183 | 0.160 |
Why?
|
| Enzyme Activation | 6 | 2018 | 3701 | 0.160 |
Why?
|
| Animals | 42 | 2018 | 168757 | 0.150 |
Why?
|
| Growth Substances | 4 | 2003 | 784 | 0.150 |
Why?
|
| Histone Code | 1 | 2018 | 163 | 0.150 |
Why?
|
| Quinolines | 2 | 2013 | 732 | 0.150 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 182 | 0.140 |
Why?
|
| Neoplasm Proteins | 3 | 2018 | 3703 | 0.140 |
Why?
|
| Pyridinium Compounds | 1 | 2016 | 84 | 0.140 |
Why?
|
| Carbon Radioisotopes | 2 | 2012 | 577 | 0.140 |
Why?
|
| Isotope Labeling | 2 | 2014 | 406 | 0.130 |
Why?
|
| Oncology Service, Hospital | 1 | 2016 | 57 | 0.130 |
Why?
|
| Retinoblastoma Protein | 2 | 2018 | 704 | 0.130 |
Why?
|
| Peptides | 6 | 2013 | 4409 | 0.130 |
Why?
|
| Antineoplastic Agents | 5 | 2018 | 13695 | 0.130 |
Why?
|
| Heterochromatin | 1 | 2018 | 296 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3508 | 0.130 |
Why?
|
| Mucins | 3 | 2003 | 564 | 0.130 |
Why?
|
| Radiology, Interventional | 1 | 2019 | 460 | 0.130 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2018 | 302 | 0.130 |
Why?
|
| Teaching Rounds | 1 | 2019 | 253 | 0.130 |
Why?
|
| Pentanoic Acids | 1 | 2014 | 15 | 0.130 |
Why?
|
| Phosphatidylcholines | 1 | 2016 | 411 | 0.120 |
Why?
|
| Oligodendroglia | 1 | 2018 | 517 | 0.120 |
Why?
|
| Signal Transduction | 8 | 2018 | 23403 | 0.120 |
Why?
|
| Radiochemistry | 2 | 2012 | 55 | 0.120 |
Why?
|
| Enzyme Inhibitors | 5 | 2008 | 3798 | 0.120 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2018 | 388 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 1097 | 0.120 |
Why?
|
| Glycogen | 1 | 2014 | 260 | 0.110 |
Why?
|
| Guanylate Cyclase | 2 | 2005 | 201 | 0.110 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2013 | 111 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2016 | 560 | 0.110 |
Why?
|
| Deoxyglucose | 1 | 2013 | 337 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2012 | 53 | 0.110 |
Why?
|
| Morpholines | 1 | 2016 | 571 | 0.110 |
Why?
|
| Muscle Proteins | 3 | 2003 | 1159 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2002 | 1703 | 0.110 |
Why?
|
| Neuropeptides | 3 | 2003 | 942 | 0.110 |
Why?
|
| Ubiquitin | 1 | 2017 | 852 | 0.110 |
Why?
|
| Magnetite Nanoparticles | 1 | 2014 | 321 | 0.110 |
Why?
|
| Diphenylamine | 2 | 2009 | 50 | 0.100 |
Why?
|
| Oncogenes | 1 | 2018 | 1265 | 0.100 |
Why?
|
| Brain Neoplasms | 3 | 2018 | 8863 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 3 | 2018 | 2727 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2018 | 2942 | 0.100 |
Why?
|
| Thymidine | 1 | 2012 | 310 | 0.100 |
Why?
|
| Substrate Specificity | 2 | 2016 | 1801 | 0.100 |
Why?
|
| Matrix Metalloproteinases | 1 | 2014 | 391 | 0.100 |
Why?
|
| Radiology Department, Hospital | 1 | 2016 | 412 | 0.100 |
Why?
|
| Cisplatin | 2 | 2009 | 1662 | 0.100 |
Why?
|
| Proteins | 4 | 2003 | 6103 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2018 | 3772 | 0.100 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 329 | 0.100 |
Why?
|
| Dipeptides | 1 | 2013 | 409 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 5 | 2018 | 6314 | 0.090 |
Why?
|
| Imidazoles | 2 | 2007 | 1206 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 584 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2018 | 2948 | 0.090 |
Why?
|
| Aminoquinolines | 1 | 2010 | 109 | 0.090 |
Why?
|
| Organometallic Compounds | 1 | 2013 | 665 | 0.090 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 494 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 1119 | 0.090 |
Why?
|
| Benzamides | 3 | 2013 | 1379 | 0.090 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2009 | 86 | 0.090 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1345 | 0.090 |
Why?
|
| Learning | 1 | 2019 | 1713 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1861 | 0.080 |
Why?
|
| Alkynes | 3 | 2015 | 306 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2016 | 5535 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2009 | 198 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2014 | 881 | 0.080 |
Why?
|
| Tissue Distribution | 4 | 2015 | 2327 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 1 | 2012 | 577 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 728 | 0.080 |
Why?
|
| Humans | 50 | 2019 | 744343 | 0.080 |
Why?
|
| Etoposide | 1 | 2009 | 641 | 0.080 |
Why?
|
| Contrast Media | 3 | 2018 | 5300 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2013 | 1125 | 0.080 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2008 | 281 | 0.080 |
Why?
|
| Receptor, erbB-2 | 2 | 2016 | 2416 | 0.080 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 941 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 789 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2018 | 2921 | 0.070 |
Why?
|
| rho-Associated Kinases | 2 | 2005 | 279 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 2109 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2018 | 3086 | 0.070 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2008 | 337 | 0.070 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 13102 | 0.070 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 931 | 0.070 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 1 | 2005 | 8 | 0.070 |
Why?
|
| Osteonectin | 1 | 2005 | 34 | 0.070 |
Why?
|
| Biosensing Techniques | 1 | 2012 | 668 | 0.070 |
Why?
|
| Receptors, Antigen | 1 | 2005 | 53 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2015 | 2942 | 0.070 |
Why?
|
| Breast Neoplasms | 3 | 2016 | 20822 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 3586 | 0.070 |
Why?
|
| HT29 Cells | 1 | 2005 | 200 | 0.070 |
Why?
|
| Dogs | 3 | 2005 | 3912 | 0.070 |
Why?
|
| Receptors, Thromboxane | 2 | 2003 | 31 | 0.070 |
Why?
|
| Virulence Factors, Bordetella | 2 | 2002 | 156 | 0.070 |
Why?
|
| Pertussis Toxin | 2 | 2002 | 178 | 0.070 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 2 | 2002 | 43 | 0.060 |
Why?
|
| Coiled Bodies | 1 | 2004 | 5 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2759 | 0.060 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2004 | 37 | 0.060 |
Why?
|
| Mutation | 7 | 2018 | 29786 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2018 | 6196 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2018 | 2282 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2005 | 409 | 0.060 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2002 | 140 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2018 | 4161 | 0.060 |
Why?
|
| Protein Binding | 3 | 2013 | 9386 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2014 | 5179 | 0.060 |
Why?
|
| Tenascin | 1 | 2004 | 59 | 0.060 |
Why?
|
| Cell Nucleolus | 1 | 2004 | 166 | 0.060 |
Why?
|
| Sulfonamides | 2 | 2012 | 1938 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 6364 | 0.060 |
Why?
|
| Models, Biological | 3 | 2015 | 9583 | 0.060 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 402 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2016 | 8428 | 0.060 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2004 | 164 | 0.060 |
Why?
|
| Gallium Radioisotopes | 2 | 2014 | 178 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 3768 | 0.060 |
Why?
|
| Thrombin | 1 | 2005 | 598 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2004 | 197 | 0.060 |
Why?
|
| Mitochondria | 1 | 2016 | 3520 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2018 | 3481 | 0.060 |
Why?
|
| Glioma | 1 | 2018 | 3401 | 0.060 |
Why?
|
| Cytokines | 1 | 2018 | 7322 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2018 | 9648 | 0.050 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2006 | 664 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2004 | 270 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 1537 | 0.050 |
Why?
|
| Kidney | 5 | 2012 | 7186 | 0.050 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 2002 | 77 | 0.050 |
Why?
|
| ADP Ribose Transferases | 1 | 2002 | 90 | 0.050 |
Why?
|
| Cysteine | 1 | 2006 | 874 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2001 | 89 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 1285 | 0.050 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2001 | 146 | 0.050 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2003 | 282 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 871 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 35421 | 0.050 |
Why?
|
| Drug Stability | 2 | 2012 | 291 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2003 | 1726 | 0.050 |
Why?
|
| Tamoxifen | 2 | 2018 | 981 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2016 | 8436 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4838 | 0.050 |
Why?
|
| Female | 18 | 2018 | 380194 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 5256 | 0.050 |
Why?
|
| Cell Cycle | 3 | 2014 | 2967 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 4042 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 2085 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2016 | 2505 | 0.040 |
Why?
|
| Forms and Records Control | 1 | 2019 | 160 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2005 | 2915 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2018 | 5172 | 0.040 |
Why?
|
| Piperidines | 1 | 2006 | 1602 | 0.040 |
Why?
|
| Genes, Retinoblastoma | 1 | 2018 | 136 | 0.040 |
Why?
|
| Nucleosides | 1 | 2018 | 138 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5221 | 0.040 |
Why?
|
| Sumoylation | 1 | 2018 | 83 | 0.040 |
Why?
|
| Chromosome Segregation | 1 | 2018 | 235 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 9274 | 0.040 |
Why?
|
| Heart Septal Defects | 1 | 2018 | 192 | 0.040 |
Why?
|
| Citrate (si)-Synthase | 1 | 2016 | 43 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 18029 | 0.040 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2016 | 92 | 0.030 |
Why?
|
| Cell Movement | 2 | 2014 | 5217 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 379 | 0.030 |
Why?
|
| Pyridines | 1 | 2007 | 2825 | 0.030 |
Why?
|
| Transfection | 4 | 2009 | 5892 | 0.030 |
Why?
|
| Integrases | 1 | 2018 | 533 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1351 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2004 | 2969 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 534 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2012 | 2187 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2018 | 836 | 0.030 |
Why?
|
| Comprehensive Health Care | 1 | 2016 | 127 | 0.030 |
Why?
|
| Kinetics | 2 | 2013 | 6473 | 0.030 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2001 | 852 | 0.030 |
Why?
|
| Melanoma | 2 | 2012 | 5510 | 0.030 |
Why?
|
| Lung | 1 | 2013 | 9856 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 561 | 0.030 |
Why?
|
| Transgenes | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 387 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 459 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 847 | 0.030 |
Why?
|
| Antimetabolites | 1 | 2014 | 125 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 826 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits | 2 | 2006 | 100 | 0.030 |
Why?
|
| Monocrotaline | 1 | 2013 | 26 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2001 | 1222 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2018 | 1460 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2014 | 5974 | 0.030 |
Why?
|
| Histones | 2 | 2018 | 2599 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 15997 | 0.030 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2012 | 61 | 0.030 |
Why?
|
| G1 Phase | 1 | 2014 | 415 | 0.030 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2014 | 246 | 0.030 |
Why?
|
| Cyclization | 1 | 2011 | 65 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2016 | 574 | 0.030 |
Why?
|
| Cell Survival | 2 | 2018 | 5882 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2016 | 695 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 2866 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 2382 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 562 | 0.030 |
Why?
|
| Click Chemistry | 1 | 2012 | 95 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2015 | 1572 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 11366 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2016 | 2716 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1692 | 0.020 |
Why?
|
| Remission Induction | 1 | 2016 | 2386 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 733 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3690 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 434 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 2012 | 0.020 |
Why?
|
| Acetylation | 1 | 2013 | 1085 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2001 | 898 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 2959 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 2 | 2003 | 611 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 190 | 0.020 |
Why?
|
| Glycolysis | 1 | 2013 | 827 | 0.020 |
Why?
|
| Ketoglutaric Acids | 1 | 2009 | 78 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 1246 | 0.020 |
Why?
|
| Tubulin | 1 | 2013 | 695 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4554 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9438 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2077 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 1547 | 0.020 |
Why?
|
| Reference Standards | 1 | 2012 | 1025 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2009 | 290 | 0.020 |
Why?
|
| Metabolomics | 1 | 2016 | 1484 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2183 | 0.020 |
Why?
|
| Time Factors | 3 | 2014 | 40075 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2016 | 2440 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2013 | 956 | 0.020 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2006 | 24 | 0.020 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2006 | 33 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2009 | 675 | 0.020 |
Why?
|
| Pyrroles | 1 | 2013 | 1146 | 0.020 |
Why?
|
| Alleles | 1 | 2018 | 6933 | 0.020 |
Why?
|
| DNA Repair | 1 | 2016 | 2046 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2014 | 828 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2008 | 463 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2016 | 3748 | 0.020 |
Why?
|
| Caspases | 1 | 2009 | 928 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2003 | 19229 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1990 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2006 | 365 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2006 | 399 | 0.020 |
Why?
|
| Cell Division | 1 | 2013 | 4568 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 627 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.020 |
Why?
|
| Echocardiography | 1 | 2018 | 5102 | 0.020 |
Why?
|
| Estrogens | 1 | 2012 | 1566 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 3846 | 0.020 |
Why?
|
| Male | 7 | 2013 | 350118 | 0.020 |
Why?
|
| Estradiol | 1 | 2012 | 2020 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2009 | 783 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3462 | 0.020 |
Why?
|
| Collagen | 2 | 2004 | 2689 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 163280 | 0.020 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 151 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 1706 | 0.010 |
Why?
|
| Genes, src | 1 | 2003 | 52 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2006 | 730 | 0.010 |
Why?
|
| RNA, Ribosomal | 1 | 2004 | 246 | 0.010 |
Why?
|
| Allantois | 1 | 2003 | 33 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2003 | 135 | 0.010 |
Why?
|
| Drug Design | 1 | 2008 | 1076 | 0.010 |
Why?
|
| Nitrobenzenes | 1 | 2003 | 65 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2019 | 4687 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2018 | 14557 | 0.010 |
Why?
|
| Middle Aged | 3 | 2013 | 213383 | 0.010 |
Why?
|
| Piperazines | 1 | 2013 | 2488 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9313 | 0.010 |
Why?
|
| Chorion | 1 | 2003 | 117 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2016 | 5021 | 0.010 |
Why?
|
| Laminin | 1 | 2004 | 419 | 0.010 |
Why?
|
| Mitosis | 1 | 2007 | 1208 | 0.010 |
Why?
|
| Solubility | 1 | 2004 | 1085 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 8301 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2003 | 2849 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2529 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2001 | 32 | 0.010 |
Why?
|
| Olfactory Mucosa | 1 | 2002 | 98 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2001 | 104 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2003 | 982 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2003 | 371 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2002 | 231 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 835 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 320 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2001 | 292 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 57776 | 0.010 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2001 | 293 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 708 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3870 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2004 | 873 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2699 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 3002 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 644 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 491 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 537 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7799 | 0.010 |
Why?
|
| Capillaries | 1 | 2003 | 773 | 0.010 |
Why?
|
| Liver | 1 | 2015 | 7474 | 0.010 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2002 | 415 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2003 | 752 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3920 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 1959 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 2219 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2001 | 509 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 2050 | 0.010 |
Why?
|
| Oxygen | 1 | 2009 | 4189 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2892 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 24260 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 2007 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1676 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2004 | 11483 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2003 | 2263 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2004 | 2504 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 2003 | 7880 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 11124 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4751 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2004 | 2924 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 3144 | 0.010 |
Why?
|
| Colon | 1 | 2002 | 1772 | 0.010 |
Why?
|
| Adult | 2 | 2013 | 214055 | 0.010 |
Why?
|
| Prostate | 1 | 2002 | 1774 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2938 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13033 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10943 | 0.010 |
Why?
|
| Brain | 1 | 2018 | 26385 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 4456 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2001 | 3036 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5853 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 56430 | 0.000 |
Why?
|